The clinical utility of anti-ribosomal P autoantibodies in systemic lupus erythematosus

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPASOTO, Sandra Gofinet
dc.contributor.authorVIANA, Vilma Santos Trindade
dc.contributor.authorBONFA, Eloisa
dc.date.accessioned2015-04-22T22:06:20Z
dc.date.available2015-04-22T22:06:20Z
dc.date.issued2014
dc.description.abstractSystemic lupus erythematosus (SLE) is a chronic inflammatory disease that can affect multiple organs and thus has a large spectrum of clinical presentations. Assessment of the autoantibody profile is fundamental for the clinical management of SLE patients, providing important data for diagnosis, clinical characterization and disease activity evaluation. Anti-ribosomal P protein (anti-Rib-P, anti-P) antibody, described in the 1980s, is a serological marker for SLE that is present in 13-20% of cases. This reactivity was initially thought to be associated with neuropsychiatric involvement in SLE, with certain conflicting results. Subsequently, associations of anti-Rib-P with liver and renal involvement in lupus were reported. Recently, anti-Rib-P was detected in autoimmune hepatitis patients. Anti-Rib-P reactivity to Trypanosoma cruzi ribosomal target antigens in patients with Chagas heart disease has also been described. This review focuses on the usefulness of the determination of anti-Rib-P in SLE and in other autoimmune and non-autoimmune disorders in clinical practice.
dc.description.indexMEDLINE
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/10490-0]
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico [301411/2009-3]
dc.description.sponsorshipFederico Foundation
dc.identifier.citationEXPERT REVIEW OF CLINICAL IMMUNOLOGY, v.10, n.11, p.1493-1503, 2014
dc.identifier.doi10.1586/1744666X.2014.966692
dc.identifier.eissn1744-8409
dc.identifier.issn1744-666X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/8891
dc.language.isoeng
dc.publisherEXPERT REVIEWS
dc.relation.ispartofExpert Review of Clinical Immunology
dc.rightsrestrictedAccess
dc.rights.holderCopyright EXPERT REVIEWS
dc.subjectanti-P
dc.subjectanti-ribosomal P antibody
dc.subjectanti-Rib-P
dc.subjectautoantibodies
dc.subjectlupus
dc.subjectsystemic lupus erythematosus
dc.subject.otherconnective-tissue diseases
dc.subject.otherprotein antibodies
dc.subject.othertrypanosoma-cruzi
dc.subject.otherdiagnostic-value
dc.subject.otherchagas-disease
dc.subject.othermembranous glomerulonephritis
dc.subject.otherpsychiatric manifestations
dc.subject.otherneuropsychiatric events
dc.subject.othercerebrospinal-fluid
dc.subject.otherassociation
dc.subject.wosImmunology
dc.titleThe clinical utility of anti-ribosomal P autoantibodies in systemic lupus erythematosus
dc.typearticle
dc.type.categoryreview
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus20
hcfmusp.contributor.author-fmusphcSANDRA GOFINET PASOTO
hcfmusp.contributor.author-fmusphcVILMA DOS SANTOS TRINDADE VIANA
hcfmusp.contributor.author-fmusphcELOISA SILVA DUTRA DE OLIVEIRA BONFA
hcfmusp.description.beginpage1493
hcfmusp.description.endpage1503
hcfmusp.description.issue11
hcfmusp.description.volume10
hcfmusp.origemWOS
hcfmusp.origem.pubmed25292164
hcfmusp.origem.scopus2-s2.0-84911475800
hcfmusp.origem.wosWOS:000344320500009
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAbraham M, 2014, RHEUMATOL INT
hcfmusp.relation.referenceAgmon-Levin N, 2009, ISR MED ASSOC J, V11, P403
hcfmusp.relation.referenceAldar H, 2012, LUPUS, V21, P1225, DOI 10.1177/0961203312451201
hcfmusp.relation.referenceAlmeida D, 2002, An Med Interna, V19, P73
hcfmusp.relation.reference[Anonymous], 1999, ARTHRITIS RHEUM, V42, P599
hcfmusp.relation.referenceArnett FC, 1996, ARTHRITIS RHEUM, V39, P1833, DOI 10.1002/art.1780391109
hcfmusp.relation.referenceAZNAR C, 1995, FEMS IMMUNOL MED MIC, V12, P231, DOI 10.1111/j.1574-695X.1995.tb00197.x
hcfmusp.relation.referenceBarkhudarova F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3244
hcfmusp.relation.referenceBertolaccini ML, 2006, ARTHRITIS RHEUM, V54, P6
hcfmusp.relation.referenceBertolaccini ML, 2006, ARTHRITIS RHEUM, V54, P4025, DOI 10.1002/art.22281
hcfmusp.relation.referenceBONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503
hcfmusp.relation.referenceBONFA E, 1993, J IMMUNOL, V150, P3917
hcfmusp.relation.referenceBriani C, 2009, J AUTOIMMUN, V32, P79, DOI 10.1016/j.jaut.2008.12.002
hcfmusp.relation.referenceCalich AL, 2013, LIVER INT, V33, P909, DOI 10.1111/liv.12155
hcfmusp.relation.referenceCAPONI L, 1995, J IMMUNOL METHODS, V179, P193, DOI 10.1016/0022-1759(94)00285-5
hcfmusp.relation.referenceCarmona-Fernandes D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-98
hcfmusp.relation.referenceChandran V, 2006, J RHEUMATOL, V33, P1987
hcfmusp.relation.referenceChindalore V, 1998, CLIN IMMUNOL IMMUNOP, V87, P292, DOI 10.1006/clin.1998.4541
hcfmusp.relation.referenceConti F, 2004, ARTHRITIS RES THER, V6, pR366, DOI 10.1186/ar1198
hcfmusp.relation.referenceCozzani E, 2014, AUTOIMMUNE DIS, V2014, DOI [10.1155/2014/321359, DOI 10.1155/2014/321359]
hcfmusp.relation.referencede Carvalho Jozélio Freire, 2010, Reumatol Clin, V6, P73, DOI 10.1016/j.reuma.2009.01.006
hcfmusp.relation.referencede Macedo PA, 2011, AUTOIMMUN REV, V10, P126, DOI 10.1016/j.autrev.2010.09.002
hcfmusp.relation.referencedo Nascimento AP, 2006, ARTHRITIS RHEUM, V54, P1568, DOI 10.1002/art.21875
hcfmusp.relation.referenceELKON K, 1986, P NATL ACAD SCI USA, V83, P7419, DOI 10.1073/pnas.83.19.7419
hcfmusp.relation.referenceELKON KB, 1985, J EXP MED, V162, P459, DOI 10.1084/jem.162.2.459
hcfmusp.relation.referenceFabien N, 1999, J AUTOIMMUN, V13, P103, DOI 10.1006/jaut.1999.0291
hcfmusp.relation.referenceFUJIMOTO M, 1995, BRIT J RHEUMATOL, V34, P908
hcfmusp.relation.referenceGerli R, 2002, RHEUMATOLOGY, V41, P1357, DOI 10.1093/rheumatology/41.12.1357
hcfmusp.relation.referenceGhirardello A, 2000, ANN RHEUM DIS, V59, P975, DOI 10.1136/ard.59.12.975
hcfmusp.relation.referenceGhirardello A, 2010, LUPUS, V19, P771, DOI 10.1177/0961203309353914
hcfmusp.relation.referenceGrippo V, 2011, PARASITOLOGY, V138, P736, DOI 10.1017/S0031182011000175
hcfmusp.relation.referenceHaddouk S, 2009, RHEUMATOLOGY, V48, P953, DOI 10.1093/rheumatology/kep142
hcfmusp.relation.referenceHanly JG, 2008, ARTHRITIS RHEUM, V58, P843, DOI 10.1002/art.23218
hcfmusp.relation.referenceHanly JG, 2011, ANN RHEUM DIS, V70, P1726, DOI 10.1136/ard.2010.148502
hcfmusp.relation.referenceHASLER P, 1994, CLIN IMMUNOL IMMUNOP, V72, P273, DOI 10.1006/clin.1994.1141
hcfmusp.relation.referenceHirohata S, 2014, MOD RHEUMATOL
hcfmusp.relation.referenceHirohata S, 2011, CLIN EXP NEPHROL, V15, P471, DOI 10.1007/s10157-011-0462-9
hcfmusp.relation.referenceHirohata S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2184
hcfmusp.relation.referenceHochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
hcfmusp.relation.referenceIsshi K, 1997, ARTHRITIS RHEUM, V40, P977
hcfmusp.relation.referenceIsshi K, 1996, ARTHRITIS RHEUM, V39, P1483, DOI 10.1002/art.1780390907
hcfmusp.relation.referenceKaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301
hcfmusp.relation.referenceKarassa FB, 2006, ARTHRITIS RHEUM, V54, P312, DOI 10.1002/art.21539
hcfmusp.relation.referenceKarimifar M, 2013, J RES MED SCI, V18, P860
hcfmusp.relation.referenceKatzav A, 2008, J AUTOIMMUN, V31, P393, DOI 10.1016/j.jaut.2008.09.002
hcfmusp.relation.referenceKatzav A, 2007, ARTHRITIS RHEUM, V56, P938, DOI 10.1002/art.22419
hcfmusp.relation.referenceKleinnijenhuis J, 2013, SCAND J RHEUMATOL, V42, P165, DOI 10.3109/03009742.2012.754941
hcfmusp.relation.referenceKOREN E, 1992, J CLIN INVEST, V89, P1236, DOI 10.1172/JCI115707
hcfmusp.relation.referenceKoscec M, 1997, J IMMUNOL, V159, P2033
hcfmusp.relation.referenceLEVIN MJ, 1991, RES IMMUNOL, V142, P157, DOI 10.1016/0923-2494(91)90029-I
hcfmusp.relation.referenceLi J, 2013, J CLIN LAB ANAL, V27, P87, DOI 10.1002/jcla.21543
hcfmusp.relation.referenceLin JLJ, 2005, CLIN EXP IMMUNOL, V141, P155, DOI 10.1111/j.1365-2249.2005.02816.x
hcfmusp.relation.referenceMahler M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2548
hcfmusp.relation.referenceMahler M, 2012, RHEUMATOL INT, V32, P691, DOI 10.1007/s00296-010-1685-x
hcfmusp.relation.referenceMahler M, 2003, J MOL MED-JMM, V81, P194, DOI 10.1007/s00109-003-0423-1
hcfmusp.relation.referenceMahler M, 2006, CLIN VACCINE IMMUNOL, V13, P77, DOI 10.1128/CVI.13.1.77-83.2006
hcfmusp.relation.referenceMassardo L, 2002, LUPUS, V11, P379, DOI 10.1191/0961203302lu209oa
hcfmusp.relation.referenceMatus S, 2007, J EXP MED, V204, P3221, DOI 10.1084/jem.20071285
hcfmusp.relation.referenceMostafa GA, 2010, J NEUROIMMUNOL, V227, P195, DOI 10.1016/j.jneuroim.2010.07.014
hcfmusp.relation.referenceMuro Y, 2009, SCAND J RHEUMATOL, V38, P460, DOI 10.3109/03009740903008767
hcfmusp.relation.referenceNagai T, 2011, MOD RHEUMATOL, V21, P57, DOI 10.1007/s10165-010-0354-y
hcfmusp.relation.referenceNagai T, 2005, ARTHRITIS RHEUM, V52, P847, DOI 10.1002/art.20869
hcfmusp.relation.referenceOhira H, 2004, HEPATOL RES, V28, P137, DOI 10.1016/j.hepres.2003.11.008
hcfmusp.relation.referenceOlesinska M, 2010, POL ARCH MED WEWN, V120, P76
hcfmusp.relation.referenceO'Neill S, 2010, BEST PRACT RES CL RH, V24, P841, DOI 10.1016/j.berh.2010.10.006
hcfmusp.relation.referencePetri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473
hcfmusp.relation.referencePisoni CN, 2014, REUMATOL CLIN
hcfmusp.relation.referencePress J, 1996, ARTHRITIS RHEUM, V39, P671, DOI 10.1002/art.1780390420
hcfmusp.relation.referenceQuintana G, 2010, AUTOIMMUN REV, V9, P750, DOI 10.1016/j.autrev.2010.06.004
hcfmusp.relation.referenceReichlin M, 2003, CLIN IMMUNOL, V108, P69, DOI 10.1016/S1521-6616(03)00063-9
hcfmusp.relation.referenceReichlin M, 1999, ARTHRITIS RHEUM, V420
hcfmusp.relation.referenceReichlin M, 1999, ARTHRITIS RHEUM, V42, P69, DOI 10.1002/1529-0131(199901)42:1<69::AID-ANR9>3.0.CO;2-J
hcfmusp.relation.referenceRekvig OP, 2012, AUTOIMMUN REV, V11, P596, DOI 10.1016/j.autrev.2011.10.021
hcfmusp.relation.referenceSanchez-Sancho F, 2010, CURR MED CHEM, V17, P423
hcfmusp.relation.referenceSCHNEEBAUM AB, 1991, AM J MED, V90, P54, DOI 10.1016/0002-9343(91)90506-S
hcfmusp.relation.referenceShor D Ben-Ami, 2014, J AUTOIMMUN
hcfmusp.relation.referenceSmith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016
hcfmusp.relation.referenceSun KH, 2001, RHEUMATOLOGY, V40, P750, DOI 10.1093/rheumatology/40.7.750
hcfmusp.relation.referenceSun KH, 1996, IMMUNOLOGY, V87, P362
hcfmusp.relation.referenceTEH LS, 1993, BRIT J RHEUMATOL, V32, P287
hcfmusp.relation.referenceTEH LS, 1992, ANN RHEUM DIS, V51, P489, DOI 10.1136/ard.51.4.489
hcfmusp.relation.referenceTektonidou MG, 2009, ARTHRIT RHEUM-ARTHR, V61, P29, DOI 10.1002/art.24232
hcfmusp.relation.referenceTsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359
hcfmusp.relation.referenceVANDAM A, 1991, J RHEUMATOL, V18, P1026
hcfmusp.relation.referenceWalker SE, 2007, DUBOIS LUPUS ERYTHEM, P286
hcfmusp.relation.referenceWeening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D
hcfmusp.relation.referenceYoshio T, 2005, J RHEUMATOL, V32, P34
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication6032e83a-1e45-4687-b844-e1ef69997c95
relation.isAuthorOfPublication798a3a64-2f34-43cc-8607-d79c1f218edd
relation.isAuthorOfPublication708e64de-56af-4523-b920-b237f71535b2
relation.isAuthorOfPublication.latestForDiscovery708e64de-56af-4523-b920-b237f71535b2
Arquivos